Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Ein aufregendes Jahr 2023 liegt hinter uns mit drei großen Highlights: Verbesserung der Erstattungslage für die koronare IVL in Deutschland, Launch des neuen koronaren IVL C2+ Katheters und die Integration des REDUCERs in die Shockwave Produktpalette!
In this Cath Lab Digest article, Dr. Yousif Ahmad of Yale School of Medicine, New Haven, Connecticut breaks down the new hospital inpatient and physician reimbursement for Coronary IVL. Dr. Ahmad shares his perspective on how the recently established CPT and DRG codes may impact the utilization of Coronary IVL in the cath lab.
Topics: Coronary IVL, Shockwave C2, Calcium Corner
Enrollments in the EMPOWER CAD study are picking up pace! Dr Nieves Gonzalo (Hospital Clìnico San Carlos, Madrid), the study’s European lead, recently shared with the medical community the journey of her first patient included in the study.
Topics: Coronary IVL, IVL Technology, SWAV News, Shockwave C2
Though sizing 1:1 to the healthy RVD may be a customary approach seen in other devices like traditional balloon angioplasty, Peripheral IVL is an exception to the rule. It's recommended to oversize Peripheral IVL by 10% (a ratio of 1.1:1) to the healthy RVD because it achieves better and sustained wall apposition, which leads to more efficient energy transfer from the IVL device.(1, 2, 3)
Topics: Peripheral IVL, Peripheral Clinical Data
für Patienten mit kalzifizierter pAVK durch periphere Intravaskuläre Lithotripsie (IVL)
Topics: Peripheral IVL, Reimbursement
Topics: Coronary IVL, IVL Technology, SWAV News, Shockwave C2
For patients with calcified PAD with Peripheral Shockwave Intravascular Lithotripsy (IVL)
Topics: Peripheral IVL, Reimbursement
What a fantastic finish! From launching the new 120-pulse Shockwave C2+ catheter in the U.S. to establishing a new Category I CPT® Add-on Code for coronary IVL, Q4 was filled with wave-making moments and positive momentum.
One highlight was the release of sex-specific outcomes data for both coronary and peripheral IVL from the DISRUPT PAD III, DISRUPT CAD III and CAD IV studies. Additionally, the DISRUPT PAD III study provided important data supporting the practice of sizing up by 10% for peripheral IVL. Look back at a few of our most noteworthy Q4 accomplishments and get excited about what’s coming in 2024 in the latest issue of the PulsePoint Newsletter.
Topics: Coronary IVL, Peripheral IVL, IVL Technology, Coronary Clinical Data, Peripheral Conferences, Peripheral Clinical Data, SWAV News, Shockwave C2, Coronary Conferences, Shockwave S4, PulsePoint Newsletter, Calcium Corner, Shockwave M5 & Shockwave M5+, Reimbursement, Treating Different Ca++ Morphologies, Female vs. Male Outcomes, Empower CAD, Reducer
In this Cath Lab Digest article, Dr. Brian Jefferson of Centennial Heart, HCA Tristar Centennial Medical Center, Nashville, Tennessee explains why the 40 additional pulses in the Shockwave C2+ catheter allows for an "IVL-first" strategy in lesions he previously reserved for atherectomy (i.e. long, diffuse lesions and multi-vessel disease).
Topics: Coronary IVL, Shockwave C2, Calcium Corner
Dr. Ziad Ali of St. Francis Hospital and Heart Center, Roslyn, New York explains the concept behind the development of the Shockwave C2+ catheter to facilitate the management of more complex, calcified lesions leading to a paradigm shift from lesion prep to vessel prep. Dr. Ali also shares his initial experiences with Shockwave C2+ including his pulse management strategy with 40 additional pulses to better treat long diffuse lesions as well as multiple calcium morphologies including eccentric and nodular calcium.
Topics: Coronary IVL, Shockwave C2, Calcium Corner
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
